Supplemental material
Emerging Microbes & Infections
Volume 10, 2021 - Issue 1
Research Article
Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice
Ji Maa KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, Rega Institute,Leuven, Belgium
https://orcid.org/0000-0002-0912-2632View further author information
https://orcid.org/0000-0002-0912-2632View further author information, Robbert Boudewijnsa KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, Rega Institute,Leuven, Belgiumhttps://orcid.org/0000-0002-5984-7279View further author information
https://orcid.org/0000-0002-5984-7279View further author information, Lorena Sanchez-Felipea KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, Rega Institute,Leuven, Belgiumhttps://orcid.org/0000-0002-6928-0931View further author information
https://orcid.org/0000-0002-6928-0931View further author information, Niraj Mishraa KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, Rega Institute,Leuven, Belgiumhttps://orcid.org/0000-0002-8679-8847View further author information
https://orcid.org/0000-0002-8679-8847View further author information, Thomas Vercruyssea KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, Rega Institute,Leuven, Belgium;b KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, Rega Institute, Leuven, Belgiumhttps://orcid.org/0000-0002-8649-777XView further author information
https://orcid.org/0000-0002-8649-777XView further author information, Dieudonné Buh Kuma KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, Rega Institute,Leuven, Belgiumhttps://orcid.org/0000-0001-8251-8230View further author information
https://orcid.org/0000-0001-8251-8230View further author information, Hendrik Jan Thibauta KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, Rega Institute,Leuven, Belgium;b KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, Rega Institute, Leuven, Belgiumhttps://orcid.org/0000-0001-5785-8276View further author information
https://orcid.org/0000-0001-5785-8276View further author information, Johan Neytsa KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, Rega Institute,Leuven, Belgium;c Global Virus Network (GVN), Baltimore, MD, USAhttps://orcid.org/0000-0002-0033-7514View further author information
https://orcid.org/0000-0002-0033-7514View further author information & Kai Dallmeiera KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, Rega Institute,Leuven, Belgium;c Global Virus Network (GVN), Baltimore, MD, USACorrespondence[email protected]
https://orcid.org/0000-0002-8117-9166View further author information
https://orcid.org/0000-0002-8117-9166View further author information show all